Stomach cancer remains one of the more preventable yet underdiagnosed malignancies in the Western world, largely because its early symptoms mimic common digestive complaints. Understanding the modifiable and non-modifiable risk factors is actionable intelligence for health-conscious adults, particularly those with a family history or lifestyle patterns that elevate risk.
Gastric cancer develops when malignant cells form in the lining of the stomach, and its incidence is strongly tied to Helicobacter pylori infection — the single most significant modifiable risk factor, affecting roughly half of the global population. Additional contributors include high-sodium diets heavy in smoked or pickled foods, tobacco use, chronic gastritis, and genetic predispositions such as hereditary diffuse gastric cancer syndrome. Treatment strategies span surgical resection, chemotherapy, targeted therapies, and immunotherapy, with prognosis heavily dependent on stage at diagnosis — early-stage five-year survival rates exceed 70%, while late-stage disease drops to below 10%.
What makes this patient-facing overview clinically relevant is the persistent gap between what's known in gastroenterology research and what patients actually understand about their own risk. H. pylori eradication therapy, for instance, has strong evidence supporting its role in reducing gastric cancer incidence by roughly 35–40% in high-risk populations, yet screening and treatment rates remain low in primary care settings outside Asia. Dietary patterns — specifically reduced processed meat consumption and higher intake of fresh fruits and vegetables — offer meaningful but modest protection. From a longevity standpoint, this article is a reminder that several major cancer risks are addressable through routine testing and lifestyle modification. Its primary limitation as a health resource is that it is general and non-quantitative, making it most useful as a starting point for a conversation with a gastroenterologist rather than a decision-making tool.